Activinsights Announces New Chief Executive Officer

Activinsights announces a new position in the executive team for Bill Hogan as Chief Executive Officer. Bill joins the Activinsights team as a proven business leader in the clinical and pharmaceutical industries.

Bill is an internationally experienced business leader with a track record in driving revenue growth and profitability in the pharma market. Throughout his career, he has used his knowledge to develop strategies and techniques that support successful integrations, mergers, and acquisition.

Prior to joining Activinsights, Bill spent 25 years at VWR/Avantor latterly as SVP and General manager for Europe. He holds a B.Sc. in Microbiology from UCL and an M.Sc. in Pathological Sciences from Sheffield.

Bill has a track record of expanding business offerings from product-only to service provisions within the global pharma market. He brings knowledge of analysing and identifying customer needs and building solutions in-line with demand.

This is an exciting time for Activinsights as clinical trials around the world are embracing remote patient monitoring to improve access and efficiency. This established trend has been accelerated by the COVID-19 crisis. Bill’s experience will help Activinsights to utilise its decade of scientific and technical expertise to develop new offerings in the digital health and clinical trials markets.

Richard Thomas, formerly Managing Director, will move to the new position of Executive Chairman where he will continue to be deeply involved in the operation and growth of the business. Richard says, “We are delighted to welcome Bill to Activinsights. The addition of Bill to the management team and Board of Directors is an important step in the company’s growth in clinical research markets.”